Login / Signup

Japanese clinical practice guidelines for vascular anomalies 2017.

Hidefumi MimuraSadanori AkitaAkihiro FujinoMasatoshi JinninMine OzakiKeigo OsugaHiroki NakaokaEiichi MoriiAkira KuramochiYoko AokiYasunori AraiNoriko AramakiMasanori InoueYuki IwashinaTadashi IwanakaShigeru UenoAkihiro UmezawaMichio OzekiJunko OchiYoshiaki KinoshitaMasakazu KuritaShien SeikeNobuyuki TakakuraMasataka TakahashiTakao TachibanaKumiko ChumanShuji NagataMitsunaga NarushimaYasunari NiimiShunsuke NosakaTaiki NozakiKazuki HashimotoAyato HayashiSatoshi HirakawaAtsuko FujikawaYumiko HoriKentaro MatsuokaHideki MoriYuki YamamotoShunsuke YuzurihaNaoaki RikihisaShoji WatanabeShinichi WatanabeTatsuo KurodaShunsuke SugawaraKosuke IshikawaSatoru Sasaki
Published in: Pediatrics international : official journal of the Japan Pediatric Society (2020)
The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.
Keyphrases
  • healthcare
  • early stage
  • squamous cell carcinoma
  • clinical practice
  • mesenchymal stem cells
  • bone marrow
  • depressive symptoms
  • health information